Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
153 items
Fundus photograph of age-related macular degeneration showing drusen.

NEI Releases Complete Data from Age-Related Eye Disease Study

The National Eye Institute (NEI), part of the National Institutes of Health (NIH), announces the release of more than 10 years of data collected during the Age-Related Eye Disease Study (AREDS).
National Eye Institute logo.

Survey Shows Americans Lack Critical Facts about Maintaining Eye Health

Most Americans do not know the risks and warning signs of diseases that could blind them if they don’t seek timely detection and treatment.
Two young boys smile at camera. A dark spot representing vision loss from AMD blocks the center of the image.

Comparison of AMD Treatments Trials (CATT): Lucentis - Avastin Trial

The National Eye Institute (NEI) of the National Institutes of Health (NIH) announces the start of a multicenter clinical trial to compare the relative safety and effectiveness of two drugs currently used to treat advanced age-related macular degeneration
Two boys smile at camera. Dark spot in center of image represents vision loss from AMD.

Laser Treatment Does Not Prevent Vision Loss for People with Early Age-Related Macular Degeneration

An extensive NIH-supported study has found that low-intensity laser treatment, thought to be possibly beneficial in slowing or preventing the loss of vision from AMD.
National Eye Institute logo.

Nuevo estudio clínico a nivel nacional evaluarí el efecto de los antioxidantes y el aceite de pescado para prevenir el avance de la degeneracin macular relacionada con la edad

Aproximadamente 100 centros clínicos están buscando 4.000 personas entre las edades de 50 a 85 años
National Eye Institute logo.

New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)

Nearly 100 Clinical Centers Are Now Seeking 4,000 Study Participants Ages 50-85 Who Have AMD
National Eye Institute logo.

Gene Found to Increase Risk of the Most Common Cause of Blindness

Investigators have identified a gene that is “strongly associated” with a person’s risk for developing age-related macular degeneration (AMD).
capsules

Review Supports Vitamin E Dosage in AREDS

NEI researchers have concluded that taking a recommended 400 international units (IU) of vitamin E each day, as part of the AREDS formulation, does not increase the risk of death of persons at risk for advanced AMD.
Fundus photograph of age-related macular degeneration showing drusen.

Vision Not Improved By Surgery for Complications of Age-Related Macular Degeneration

Vision does not improve substantially for patients with age-related macular degeneration (AMD) who undergo surgery to remove lesions of new blood vessels, scar tissue, or possible bleeding beneath the retina.
National Eye Institute logo.

Statement on the Prevalence of Diabetic Retinopathy and Age-related Macular Degeneration Among Hispanic/Latino Americans

A new study projects that nearly half of all adult Hispanic/Latino individuals in the United States with diabetes have some type of diabetic retinopathy, a degenerative disease affecting vision.

Want more news from NEI?

Connect with us through social media to stay up to date on vision research, eye health, and other topics!

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248